Malaria and Age Variably but Critically Control Hepcidin Throughout Childhood in Kenya

Sarah H Atkinson1, Sophie M Uyoga2, Andrew E Armitage3

  • 1Kenya Medical Research Institute (KEMRI) - Wellcome Trust Research Programme (KWTRP), PO Box 230-80108, Kilifi, Kenya ; Department of Paediatrics, Oxford University Hospitals, University of Oxford, Oxford, UK ; Oxford University Clinical Academic Graduate School, Oxford, UK.

Ebiomedicine
|December 3, 2015
PubMed

Insights

Malaria in African children, both symptomatic and asymptomatic, increases hepcidin levels, which impairs iron absorption. This suggests malaria contributes significantly to iron deficiency (ID) and may reduce iron supplementation effectiveness.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Nutritional Science

Background:

  • Iron deficiency (ID) and malaria are prevalent in African children.
  • Hepcidin, an iron-regulatory hormone, is known to be induced by malaria, but longitudinal data are limited.

Purpose of the Study:

  • To investigate the longitudinal relationship between malaria and hepcidin concentrations in Kenyan children.
  • To assess the impact of malaria on iron status and the risk of future febrile illnesses.

Main Methods:

  • Longitudinal study of 324 Kenyan children (≤8 years) with intensive surveillance for malaria.
  • Measurement of hepcidin concentrations, iron status markers, and malaria antibody titers during two cross-sectional surveys.
  • Analysis of associations between malaria status, antibody titers, and hepcidin levels.

Main Results:

  • Hepcidin concentrations were highest in young infants and females, declining with age.
  • Asymptomatic malaria and malaria antibody titers positively correlated with hepcidin levels.
  • Febrile malaria episodes were linked to transiently high hepcidin levels, but hepcidin did not predict future illness risk.

Conclusions:

  • Malaria, both symptomatic and asymptomatic, contributes to iron deficiency in African children by increasing hepcidin and impairing iron absorption.
  • The effectiveness of iron supplementation may be compromised in children with asymptomatic malaria.
  • Malaria prevention and elimination strategies could concurrently address a major cause of iron deficiency in this population.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
373
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
330
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.4K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
462
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
3.1K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
316